Skip to Main Content

Paper Details

Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant.
JCI Insight
49
2018
MDS, azacitidine, exome, hematopoietic cell, myelodysplastic syndromes, patients, subclone, subclones, tumor
Author NameAffiliation
Christopher A Miller
Christopher A MillerMcDonnell Genome Institute, Washington University School of Medicine
Robert S FultonMcDonnell Genome Institute, Washington University School of Medicine
Robert S FultonMcDonnell Genome Institute, Washington University School of Medicine
Catrina FronickMcDonnell Genome Institute, Washington University School of Medicine
Michelle O'LaughlinMcDonnell Genome Institute, Washington University School of Medicine
Sharon E Heath
Daniel C Link
John F DiPersio
Peter Westervelt
Timothy J Ley
Timothy A GraubertMassachusetts General Hospital Cancer Center
Matthew J Walter
  • 1 - 13

Datasets